134 related articles for article (PubMed ID: 7268998)
1. Is urinary cholesterol determination a possible screening test for urological carcinomas?
Jüngst D; Tauber R; Osterholzer M; Karl HJ
Urol Res; 1981; 9(1):1-3. PubMed ID: 7268998
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of cholesterol excretion in the urine].
Jüngst D; Osterholzer M; Lazik E; Karl HJ
Acta Med Austriaca Suppl; 1979; 6():406-9. PubMed ID: 299242
[TBL] [Abstract][Full Text] [Related]
3. Studies on the clinical significance of nonesterified and total cholesterol in urine.
Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
[TBL] [Abstract][Full Text] [Related]
4. Urinary cholesterol in cancer screening.
Jüngst D; Osterholzer M; Tauber R; Karl HJ
Urology; 1982 Nov; 20(5):495-8. PubMed ID: 7147529
[TBL] [Abstract][Full Text] [Related]
5. Urinary cholesterol in follow-up of patients with urologic carcinomas or benign prostatic hyperplasia.
Jüngst D; Tauber R; Lazik E; Karl HJ
Urology; 1981 Jul; 18(1):65-7. PubMed ID: 6167049
[TBL] [Abstract][Full Text] [Related]
6. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
7. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of urinary basic fetoprotein (BFP) in patients with urological malignancies].
Tsujii T; Yonese J; Kojima S; Tari K; Ishii M; Seino Y
Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):829-34. PubMed ID: 1698231
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
10. [Urine polyamine in patients with malignant urological diseases using a polyamine-test enzyme kit].
Sakai S; Koide T; Ito Y; Tei K; Deguchi T; Matsuda S; Kato N; Ban Y; Nishiura T
Hinyokika Kiyo; 1986 May; 32(5):661-5. PubMed ID: 3751793
[TBL] [Abstract][Full Text] [Related]
11. Incidence of urological cancers in neurological patients: a review of the literature from the EAU Young Academic Urologist Functional Group.
Cancrini F; Osman N; Doizi S; Guillot-Tantay C; Hüsch T; Illiano E; Tutolo M; Tienza A; Culha MG; Vale L; Raison N; Herve F; Grande P; Roupret M; Phé V
Minerva Urol Nephrol; 2023 Apr; 75(2):163-171. PubMed ID: 36999836
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
[TBL] [Abstract][Full Text] [Related]
13. Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols?
Vasdev N; Thorpe AC
Urol Oncol; 2013 Aug; 31(6):909-13. PubMed ID: 21917488
[TBL] [Abstract][Full Text] [Related]
14. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
15. Urinary cholesterol. VII. The significance of the excretion of nonesterified cholesterol in patients with uterine carcinomas.
Acevedo HF; Campbell EA; Frich JC; Merkow LP; Hayeslip D; Gilmore J
Cancer; 1975 Oct; 36(4):1459-69. PubMed ID: 1175140
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
17. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation.
Ho KJ; Kuo SH
Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129
[TBL] [Abstract][Full Text] [Related]
18. [Value of urinary cytology in urological diagnosis. Report after ten years (author's transl)].
Jocham D; Göttinger H; Schmiedt E
Urologe A; 1982 Mar; 21(2):79-83. PubMed ID: 7200668
[TBL] [Abstract][Full Text] [Related]
19. [Electron paramagnetic resonance determination of ceruloplasmin concentration in the blood of patients for the diagnosis of urological cancer diseases].
Ibragimova MI; Chushnikov AI; Moiseev VN; Petukhov VIu; Zheglov EP; Pogorel'tsev VI; Khardina NB
Klin Lab Diagn; 2010 Apr; (4):17-20. PubMed ID: 20524342
[TBL] [Abstract][Full Text] [Related]
20. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Kazama T; Katayama T; Yamazaki N
Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
